Biotech company 23andMe had a rough 2024, including a $30 million settlement payment after customer data was compromised.

In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

GSK PLC GSK shares were unchanged Friday at £13.50, on what proved to be an all-around grim trading session for the stock ...

Shares of GSK PLC GSK inched down 0.77% to £13.50 Thursday, on what proved to be an all-around positive trading session for ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...

When children receive their second measles-mumps-rubella vaccine, around the time they start kindergarten, they gain protection against all three viruses for all or most of their lives.

kerala lottery result 26 Well-known pharmaceutical company sold for 360 million Chinese biopharmaceutical ROCK2 inhibitor has been approved for clinical trials and is now underway in the U.S. GSK ...

INR:2093. rummy 11 circle app download The number of cross-provincial direct settlements for medical treatment exceeded 4.24 million, and the officia ...

coolbet logo PNAS: Antibiotics could treat opioid addiction GlaxoSmithKline signs 150 million euro partnership to develop next-generation mRNA COVID-19 vaccine Beyond the limits of human eyes! AI ...

And this is an important principle for dividend investors to follow. Assessing GSK from an investment perspective involves figuring out how these will fare against competitors like Zostavo (made ...